Alexion Pharmaceuticals, Inc. (ALXN) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)

An SI Board Since October 1997

Posts	SubjectMarks	Bans	Symbol
824	29	0	ALXN

Emcee: Larry Liebman	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
674	Amaranth had $16m in alxn puts as of 9/30/06.	keokalani'nui	-	10/11/2006
673	ALXN a buyout possible? Wachovia says with a B.L.A. and M.A. filed in the U.S.	IRWIN JAMES FRANKEL	-	10/9/2006
672	Hope Leeds Today gets delivered to NICE headquarters.	keokalani'nui	-	9/27/2006
671	The drug trial triumph that's changing lives FOR years, sometimes decades,	Icebrg	-	9/27/2006
670	Alexion Submits Market Authorization Application for Soliris(TM) (eculizumab) in	kenhott	-	9/26/2006
669	Here's the dosage from the trial: <i>eculizumab was given at a dose o	Biomaven	-	9/22/2006
668	I must have reverse AD -- I'm remembering things that never happened. I t	Ian@SI	-	9/22/2006
667	This is no cure - presumably have to keep giving the drug forever. But it had th	Biomaven	-	9/22/2006
666	Are you suggesting that ALXN erred in developing a cure rather than following Bi	Ian@SI	-	9/21/2006
665	I just read the NEJM article, and all I can say that is the most convincing smal	Biomaven	-	9/21/2006
664	<pnh> I understand that is covered if not issued.	kenhott	-	9/21/2006
663	Whole press release at: eurekalert.org Public Release: 21-Sep-2006 New England	Ian@SI	-	9/21/2006
662	Update. I just looked through the issued and application patent databases under	keokalani'nui	-	9/21/2006
661	Solaris is more a threat to bone marrow transplant than the other way around. I	keokalani'nui	-	9/21/2006
660	There's a couple of things that I know of. Cure can be achieved by bone mar	kenhott	-	9/21/2006
659	<Alexion has requested Priority Review designation for this BLA from the FDA.	kenhott	-	9/21/2006
658	Does anyone here keep track of any upcoming competition in this indication? I se	Biomaven	-	9/21/2006
657	Thanks I am hoping for 3 or 4 months. Thinking that with extraordinary P-value	IRWIN JAMES FRANKEL	-	9/20/2006
656	I believe they will take their time. In this case 6 months. The critical questio	Icebrg	-	9/20/2006
655	So how long will it take FDA to approve this one? ij	IRWIN JAMES FRANKEL	-	9/20/2006
654	Alexion Pharmaceuticals Submits Biologics License Application for Soliris(TM) (e	Icebrg	-	9/20/2006
653	This program has not moved quickly at all and others have made real progress in	keokalani'nui	-	9/17/2006
652	A rationally designed agonist antibody fragment that functionally mimics thrombo	Icebrg	-	9/17/2006
651	Priced In at Alexion By Marc Lichtenfeld Senior Columnist 9/1/2006 7:19 AM EDT	Doc Bones	-	9/1/2006
650	Squeeeeeeze or not nice rally on 3X normal volume. ij	IRWIN JAMES FRANKEL	-	8/29/2006

Go to reply# or date (mm/dd/yy):